When it comes to starting a family, timing is everything
A new Cochrane review of methods to increase chances of successful conception suggests that timed intercourse using urine ovulation tests probably improves live birth and pregnancy rates in women under 40 who had been trying to conceive for under a year.
2023-09-15
(Press-News.org) The review, conducted jointly with researchers from Oxford University, the Royal Berkshire Hospital in Reading, and the Princess Anne Hospital in Southampton, included seven randomised controlled trials involving 2,464 women or couples who had been trying to conceive.
Each month there is a narrow window for successful conception due to the limited lifespan of the sperm and egg, which begins from around five days before ovulation (egg release) and lasts until several hours afterwards.
The period of a woman’s cycle can be identified by different methods, including urine ovulation tests (dipstick devices that can detect changes in hormones released into the urine, signifying when ovulation will occur), fertility awareness-based methods (FABM) (including calendar tracking, monitoring changes in cervix fluid and body temperature) or identifying when the egg is released on ultrasound. This review aimed to assess the benefits and risks of timed intercourse on pregnancy, live birth, negative effects and quality of life in couples trying to conceive.
The study found that timing intercourse around the fertile period using a urine ovulation test increased the chances of pregnancy and live birth to between 20% to 28%, compared to 18% without using urine ovulation tests. This was specifically in women under 40 trying to conceive for under 12 months.
Tatjana Gibbons, a DPhil researcher at Oxford’s Nuffield Department of Women's & Reproductive Health and lead author on the study, said: ‘‘Many couples find it difficult to achieve a pregnancy, which can lead to concerns about their fertility.'
‘The finding that a simple and easily available urine test can increase a couple’s chance of successful conception is quite exciting because it can empower couples with more control over their fertility journey and could potentially reduce the need for infertility investigations and treatments.’
Professor Christian M Becker of Nuffield Department of Women's & Reproductive Health said: ‘The high threshold of evidence required in a Cochrane review makes even this moderate quality evidence for the effectiveness of urine ovulation tests quite impressive, as well as surprising considering how long they have been available for.’
However, the researchers cautioned that because many of the studies were funded by the manufacturers of the urine ovulation test, the results should be interpreted with caution.
They also found that there was insufficient evidence to conclude the effect of the other methods in the study, including timed intercourse on clinical pregnancy (ultrasound-confirmed pregnancy), the use of FABM in timed intercourse compared to intercourse without ovulation prediction.
- END -
ADDITIONAL INFORMATION
For further information or interviews with the article author, please contact:
Chris McIntyre
Media Relations Manager
University of Oxford
tel (direct): 01865 270 046
tel (News Office): 01865 280528
Christopher.mcintyre@admin.ox.ac.uk
NOTES TO EDITOR
The paper, ‘Timed intercourse for couples trying to conceive’ is published in Cochrane. [LINK] DOI: 10.1002/14651858.CD011345.pub3.
About the University of Oxford
Oxford University has been placed number 1 in the Times Higher Education World University Rankings for the seventh year running, and number 2 in the QS World Rankings 2022. At the heart of this success are the twin-pillars of our ground-breaking research and innovation and our distinctive educational offer.
Oxford is world-famous for research and teaching excellence and home to some of the most talented people from across the globe. Our work helps the lives of millions, solving real-world problems through a huge network of partnerships and collaborations. The breadth and interdisciplinary nature of our research alongside our personalised approach to teaching sparks imaginative and inventive insights and solutions.
Through its research commercialisation arm, Oxford University Innovation, Oxford is the highest university patent filer in the UK and is ranked first in the UK for university spinouts, having created more than 200 new companies since 1988. Over a third of these companies have been created in the past three years. The university is a catalyst for prosperity in Oxfordshire and the United Kingdom, contributing £15.7 billion to the UK economy in 2018/19, and supports more than 28,000 full time jobs.
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-09-15
A major new study has revealed that American teenagers are more likely than any other nationality to brag about their math ability.
Research using data from 40,000 15-year-olds from nine English-speaking nations internationally found those in North America were the most likely to exaggerate their mathematical knowledge, while those in Ireland and Scotland were least likely to do so.
The study, published in the peer-reviewed journal Assessment in Education: Principles, Policy & Practice, used responses from the OECD Programme for International Student Assessment (PISA), in which participants took a two-hour maths test alongside a ...
2023-09-15
Women could be opting to have unnecessary surgery to avoid breast cancer, after being told they are at high risk from genetic test results which do not take family history into account.
The authors of new research led by the University of Exeter have warned that women who discover, outside of a clinical setting, that they carry a disease-causing variant in one of the BRCA genes (BRCA1 or BRCA2) may be told their risk of breast cancer is 60-80 per cent. In fact, the risk could be less than 20 per cent if they do not have a close relative with the condition.
The warning has emerged in a paper published today in the Lancet journal eClinical Medicine. Until recently, women who ...
2023-09-14
LISLE, Ill. (September 14, 2023) — The Morton Arboretum in Lisle, Ill., announced it will receive $15 million in federal funding from the U.S. Forest Service through the Inflation Reduction Act (IRA) to expand and improve the tree canopy in disadvantaged communities throughout Illinois. The funding is part of a historic $1 billion investment to boost the nation’s urban tree cover in communities nationwide. The federal grant funding the Arboretum will receive is the largest award in Illinois, the largest award to a public garden in the country and a historic sum for the nonprofit tree-focused organization.
The U.S. ...
2023-09-14
A team of scientists with the Department of Energy’s Oak Ridge National Laboratory has investigated the behavior of hafnium oxide, or hafnia, because of its potential for use in novel semiconductor applications.
Materials such as hafnia exhibit ferroelectricity, which means that they are capable of extended data storage even when power is disconnected and that they might be used in the development of new, so-called nonvolatile memory technologies. Innovative nonvolatile memory applications will pave the way for the creation of bigger and faster computer systems by alleviating the heat generated from the continual ...
2023-09-14
Rochester Institute of Technology’s Gabriel Diaz, associate professor in the Chester F. Carlson Center for Imaging Science, has earned the Research to Prevent Blindness/Lions Clubs International Foundation Low Vision Research Award (LVRA), in collaboration with researchers at the University of Rochester.
The award is given annually to provide funding for innovative research, which demonstrates out-of-the-box thinking, focuses on the visual system that is damaged, and seeks greater understanding of how the visual system and brain respond to severe and chronic visual ...
2023-09-14
ITHACA, N.Y. -- To help respond to emerging and established vector-borne threats, the Northeast Regional Center for Excellence in Vector-Borne Diseases (NEVBD), led by Cornell, has received a five-year, $8.7 million award from the Centers for Disease Control and Prevention (CDC) to train and educate current and future vector-borne disease professionals and to evaluate the effectiveness of community and regional prevention strategies.
The award, effective as of July, follows $10 million in ...
2023-09-14
NEW YORK, NY, Sept. 14, 2023--A study led by Columbia obstetricians has shown that a new intrauterine device can rapidly control postpartum hemorrhage, a major cause of severe maternal morbidity and death, in real-world situations.
“Our findings show that the device is an important new tool in managing postpartum bleeding,” says Dena Goffman, MD, professor of obstetrics and gynecology at Columbia University Vagelos College of Physicians and Surgeons and senior author of the study.
“We had ...
2023-09-14
Weill Cornell Medicine has been awarded a five-year, $5 million grant from the United States Department of Health and Human Services through the Office of Population Affairs under the Teen Pregnancy Prevention Program to conduct a randomized trial testing whether a bilingual video game called “No Baby No (No Bebé No)” can increase the use of contraception among sexually active Black and Hispanic adolescents.
“Nine out of ten teens play video games. No Baby No empowers Black and Hispanic adolescents to learn about contraception, and the potential consequences of not using it, in a risk-free virtual ...
2023-09-14
Philadelphia, September 14, 2023 – Up to an hour after their hearts had stopped, some patients revived by cardiopulmonary resuscitation (CPR) had clear memories afterward of experiencing death and had brain patterns while unconscious linked to thought and memory, report investigators in the journal Resuscitation, published by Elsevier.
In a study led by researchers at NYU Grossman School of Medicine, in cooperation with 25 mostly US and British hospitals, some survivors of cardiac arrest described lucid death experiences that occurred while they were seemingly unconscious. Despite immediate treatment, fewer than 10% of the 567 patients studied, ...
2023-09-14
Until quite recently, it was extremely difficult to detect the variants underlying many genetic disorders. In the absence of a defined cause, clinicians have little to guide treatment for those left without a genetic diagnosis, forcing patients and families to embark on a diagnostic odyssey with no guarantee of finding answers.
A decade ago, sequencing centers began offering clinical whole exome sequencing, but these only cover the portion of the genome that codes for proteins – approximately 1.5 percent of the entire genome. While relatively successful, the diagnostic yield for most clinical exome sequencing programs is roughly 25 percent, leaving 75 percent of cases without ...
LAST 30 PRESS RELEASES:
[Press-News.org] When it comes to starting a family, timing is everything
A new Cochrane review of methods to increase chances of successful conception suggests that timed intercourse using urine ovulation tests probably improves live birth and pregnancy rates in women under 40 who had been trying to conceive for under a year.
